Roberto Perez

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
    Roberto Perez
    Veterans Affairs Medical Center, Miami, FL, USA
    Oncotarget 3:988-97. 2012
  2. doi request reprint LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia
    Ferenc G Rick
    Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida 33125, USA
    Prostate 71:736-47. 2011
  3. pmc Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist
    Ferenc G Rick
    Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, FL 33125, USA
    Proc Natl Acad Sci U S A 110:2617-22. 2013
  4. pmc Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia
    Ferenc G Rick
    Veterans Affairs Medical Center, Miami, FL 33125, USA
    Proc Natl Acad Sci U S A 108:3755-60. 2011
  5. pmc Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
    Ferenc G Rick
    Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL, USA
    Cell Cycle 11:2518-25. 2012

Detail Information

Publications5

  1. pmc Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
    Roberto Perez
    Veterans Affairs Medical Center, Miami, FL, USA
    Oncotarget 3:988-97. 2012
    ..Further studies on GHRH antagonists may facilitate the development of new strategies for the treatment of resistant cancers...
  2. doi request reprint LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia
    Ferenc G Rick
    Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida 33125, USA
    Prostate 71:736-47. 2011
    ..We investigated the mechanism of action and effect of Cetrorelix in a rat model of BPH...
  3. pmc Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist
    Ferenc G Rick
    Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, FL 33125, USA
    Proc Natl Acad Sci U S A 110:2617-22. 2013
    ..GRP antagonists should be considered for further development as therapy for BPH...
  4. pmc Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia
    Ferenc G Rick
    Veterans Affairs Medical Center, Miami, FL 33125, USA
    Proc Natl Acad Sci U S A 108:3755-60. 2011
    ..This study sheds light on the mechanism of action of GHRH antagonists in BPH and suggests that GHRH antagonists should be considered for further development as therapy for BPH...
  5. pmc Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers
    Ferenc G Rick
    Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, Miami, FL, USA
    Cell Cycle 11:2518-25. 2012
    ..single substances (p < 0.05) was significantly greater. These findings support the use of RC-3940-II as an anticancer agent and may help to design clinical trials using RC-3940-II in combinations with cytotoxic agents...